FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

33629411000001108: Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Dec 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2122981000001114 Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2122991000001111 Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
101440501000001119 Leveraxo 20mg modified release tablets (Mylan Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
101440601000001115 Leveraxo 20mg modified release tablets (Mylan Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
102365401000001112 Leveraxo 20mg modified-release tablets (Mylan Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
105778501000001112 Leveraxo 20mg modified-release tablets (Mylan) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Is a Oxycodone hydrochloride 20mg m/r tablet false Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Has active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Is a Leveraxo true Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Is a Oxycodone 20mg modified-release tablets false Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Is a Oxycodone 20mg modified-release tablets true Inferred relationship Existential restriction modifier
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) 56 tablet 4 x 14 tablets Has AMP True Leveraxo 20mg modified-release tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start